Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial-Reference-Cited by-同舟云学术

Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial

Published:2015-06-29 Issue:4 Volume:117 Page:629-635
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Karam Jose A.¹,Devine Catherine E.²,Fellman Bryan M.³,Urbauer Diana L.³,Abel E. Jason⁴,Allaf Mohamad E.⁵,Bex Axel⁶,Lane Brian R.⁷,Thompson R. Houston⁸,Wood Christopher G.¹

Affiliation:

1. Department of Urology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Radiology; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX USA

4. Department of Urology; University of Wisconsin School of Medicine and Public Health; Madison WI USA

5. The James Buchanan Brady Urological Institute and Department of Urology; The Johns Hopkins University School of Medicine; Baltimore MD USA

6. Division of Surgical Oncology; Department of Urology; The Netherlands Cancer Institute; Amsterdam The Netherlands

7. Division of Urology; Spectrum Health Hospital System; Michigan State University; Grand Rapids MI USA

8. Department of Urology; Mayo Clinic; Rochester MN USA

Funder

Pfizer

National Institutes of Health/National Cancer Institute (NIH/NCI)

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13188/fullpdf

Reference23 articles.

1. Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery;Bex;World J Urol,2009

2. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus;Cost;Eur Urol,2011

3. Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma;Cowey;J Clin Oncol,2010

4. Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib;Harshman;Nat Rev Urol,2009

5. Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma;Hellenthal;J Urol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Therapy in Locally Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

2. Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma;European Urology Oncology;2021-05

3. Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma;Urologic Clinics of North America;2020-08

4. Perioperative therapies for urological cancers;Japanese Journal of Clinical Oncology;2020-03-02

5. Pharmacokinetics of Neoadjuvant Axitinib Influenced the Efficacy in Patients With Advanced Renal Cell Carcinoma;The Journal of Clinical Pharmacology;2019-09-19